Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Spinner

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Blood Advances|June 23, 2020
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasmsMichael A Spinner, Alexey Aleshin, Marianne T Santaguida, et al.
The American Journal of Bioethics : AJOB|September 13, 2013
What does the duty to warn require?Seema K Shah, Sara Chandros Hull, Michael A Spinner, et al.
Chest|June 5, 2021
Pulmonary Manifestations of GATA2 DeficiencyBeatriz E Marciano, Kenneth N Olivier, Les R Folio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Blood Advances|October 1, 2020
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphomaPaola Ghione, Promie Faruque, Neha Mehta-Shah, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Blood Advances|August 21, 2019
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohortMichael A Spinner, Vanessa E Kennedy, John S Tamaresis, et al.
Blood Advances|January 4, 2018
HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activityMichael A Spinner, Marcelo Fernández-Viña, Lisa E Creary, et al.
Blood|July 22, 2021
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell ProjectRanjana H Advani, Tetiana Skrypets, Monica Civallero, et al.
Blood|March 1, 2023
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agentsMichael A Spinner, R A Sica, John S Tamaresis, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Blood Advances|June 23, 2020
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasmsMichael A Spinner, Alexey Aleshin, Marianne T Santaguida, et al.
The American Journal of Bioethics : AJOB|September 13, 2013
What does the duty to warn require?Seema K Shah, Sara Chandros Hull, Michael A Spinner, et al.
Chest|June 5, 2021
Pulmonary Manifestations of GATA2 DeficiencyBeatriz E Marciano, Kenneth N Olivier, Les R Folio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Blood Advances|October 1, 2020
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphomaPaola Ghione, Promie Faruque, Neha Mehta-Shah, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Blood Advances|August 21, 2019
Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohortMichael A Spinner, Vanessa E Kennedy, John S Tamaresis, et al.
Blood Advances|January 4, 2018
HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activityMichael A Spinner, Marcelo Fernández-Viña, Lisa E Creary, et al.
Blood|July 22, 2021
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell ProjectRanjana H Advani, Tetiana Skrypets, Monica Civallero, et al.
Blood|March 1, 2023
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agentsMichael A Spinner, R A Sica, John S Tamaresis, et al.
Pageof 5